Tetrapeptide-21
Tetrapeptide-21 (Lys-Asp-Val-Tyr) is a collagen-stimulating tetrapeptide that activates TGF-beta signaling in dermal fibroblasts to upregulate type I and III collagen synthesis. Compatible with Matrixyl and GHK-Cu.
Community Rating
No ratings yet
Compound Profile
Tetrapeptide-21
Key Data
Research reference only
Research Focus
Preclinical data
⚠ Research & Educational Use Only. Tetrapeptide-21 is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Activates TGF-β/SMAD signaling pathway in dermal fibroblasts → upregulates type I and type III procollagen synthesis
- Increases collagen type I mRNA expression by up to 200% in cell culture studies vs control
- Reduces matrix metalloproteinase (MMP-1) expression — prevents collagen degradation alongside promoting its synthesis
- Tetrapeptide-21 is not FDA-approved for human use. Cosmetic ingredient (INCI: Tetrapeptide-21). Regulated as a cosmetic active ingredient.
Research At a Glance
- Activates TGF-β/SMAD signaling pathway in dermal fibroblasts → upregulates type I and type III procollagen synthesis
- Increases collagen type I mRNA expression by up to 200% in cell culture studies vs control
- Reduces matrix metalloproteinase (MMP-1) expression — prevents collagen degradation alongside promoting its synthesis
- Well-validated collagen-building mechanism shared with palmitoyl peptides (Matrixyl), providing additive potential
In Plain English
Simple summaryTetrapeptide-21 (Arg-Lys-Arg-Lys or related sequences, also known as Chronogen) is a cosmetic peptide designed to stimulate collagen and ECM component production in aging skin. It acts on the extracellular matrix-producing machinery of dermal fibroblasts, specifically proposed to upregulate type I and type IV collagen synthesis and fibronectin production. The tetrapeptide structure is small enough to penetrate the stratum corneum when appropriately formulated, reaching the dermis where fibroblasts are located. Brand studies with 5% concentration in cream show improvements in skin firmness and reduction of fine lines at 28-day evaluation in small study populations.
- Activates TGF-β/SMAD signaling pathway in dermal fibroblasts → upregulates type I and type III procollagen synthesis
- Increases collagen type I mRNA expression by up to 200% in cell culture studies vs control
- Reduces matrix metalloproteinase (MMP-1) expression — prevents collagen degradation alongside promoting its synthesis
The full scientific detail, mechanisms, citations, and dosing data, follows below.
What is Tetrapeptide-21?
Tap any underlined term for an instant definition.
Tetrapeptide-21 (Lys-Asp-Val-Tyr) is a synthetic collagen-stimulating tetrapeptide designed to activate the TGF-β (transforming growth factor beta) signaling pathway in dermal fibroblasts. It represents the smaller, unmodified tetrapeptide approach to collagen stimulation, in contrast to fatty acid-conjugated peptides like palmitoyl pentapeptide-4 (Matrixyl) or palmitoyl tripeptide-1.
**Mechanism of action:** Tetrapeptide-21 binds to TGF-β receptor complexes or upstream co-receptors on fibroblasts, activating the SMAD2/3 intracellular signaling cascade that drives procollagen gene transcription. Key effects:
1. **Procollagen type I alpha 1 (COL1A1)**: Upregulation of gene expression for the major structural collagen of dermis 2. **Procollagen type III (COL3A1)**: Upregulation of the "reticulin" collagen predominant in younger skin 3. **TIMP-1 (Tissue Inhibitor of Metalloproteinase-1)**: Increased expression inhibits MMP collagenases 4. **MMP-1 suppression**: Reduces collagenase activity in the dermal microenvironment
The combination of stimulating new collagen synthesis AND reducing collagen breakdown produces a net increase in dermal collagen content.
**Positioning within cosmetic peptide landscape:** Tetrapeptide-21 occupies a position similar to palmitoyl tripeptide-1 (Pal-GHK) in that both stimulate collagen via related TGF-β pathways. The key difference is that Pal-GHK has an N-terminal palmitoyl modification that enhances lipophilicity and skin penetration through the stratum corneum, while Tetrapeptide-21 is unmodified and hydrophilic — requiring appropriate delivery systems (nanoparticles, liposomes, or high formulation concentration) for optimal penetration.
When combined with Matrixyl (palmitoyl pentapeptide-4), which acts through distinct TGF-β and decorin-related pathways, Tetrapeptide-21 may provide complementary or additive collagen stimulation. Multi-peptide anti-aging serums increasingly incorporate 3-5 different peptide actives targeting different pathways simultaneously.
By the Numbers
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Tetrapeptide-21. See all Skin & Anti-Aging peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Cosmetic formulation concentrations:
Standard anti-aging serum: 0.5-5% concentration Combination with Matrixyl: 1-3% each for synergistic collagen stimulation Day/night creams: 1-2% in emulsion base
Application: 1-2x daily after cleansing, before moisturizer
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Applied topically in serum or cream. Particularly effective in combination with retinoids, vitamin C, and other collagen-stimulating actives. Stable at skin-compatible pH (5-7).
What the research doesn't show
Like most cosmetic peptide ingredients, Tetrapeptide-21's evidence base is dominated by ingredient manufacturer data. The collagen stimulation mechanism in fibroblast cultures is real; whether topically applied tetrapeptide reaches the dermis in clinically effective concentrations in humans requires independent validation that doesn't currently exist in the published literature.
Medical Expert Videos
Physicians, researchers, and pharmacologists explain Tetrapeptide-21, covering mechanisms of action, clinical context, and study findings.
Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.
The Bottom Line
Tetrapeptide-21 has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: activates tgf-β/smad signaling pathway in dermal fibroblasts → upregulates type i and type iii procollagen synthesis.
The most commonly reported side effect in research subjects is excellent tolerability profile. It is a research chemical, not approved for human use.
Frequently Asked Questions
Explore Further
Quick Reference
How It Compares
Palmitoyl pentapeptide-4 (Matrixyl) is the most commercially dominant collagen-stimulating cosmetic peptide with the most independent data. Palmitoyl tripeptide-1 and tetrapeptide-7 round out the Matrixyl 3000 combination. Tetrapeptide-21 is a competitor to the Matrixyl approach rather than a complement. Among collagen-stimulating cosmetic peptides, Matrixyl has more published independent evidence than Tetrapeptide-21.
Compare Tetrapeptide-21 side-by-sideResearch Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.